Speaking on Sunday, Dr. Esmayeel Saberfar, the CEO of a knowledge-based company active in producing flu vaccines, said his company has obtained the technical know-how for the development of the vaccine after ten years of research and experiment.
“Manufacturers of this type of vaccine are in France, Germany, Belgium, the US, Italy, Japan, and South Korea; foreign-made flu vaccines are currently being used in the country,” he said.
According to him, about $8 million worth of these vaccines are imported annually, adding that the domestic production of the vaccines would save the country the same amount of forex.
“Although the vaccine has not yet been mass-produced, other countries such as India, Pakistan and the United Arab Emirates (UAE) have already made a request for it,” he added.
The Iranian flu vaccine can rival those manufactured by France, he said, adding that the vaccine would hit the Iranian market sometime in September 2020.
Iran has taken long strides in producing different types of drugs and medical equipment and exported them to many foreign states.
In September, a senior official at the Food and Drug Administration of Iran said that the country has exported hundreds of different types of medical equipment to over 50 world states in the first six months of the current Iranian year (started on March 21) despite the US tough sanctions.
"Fortunately, 30 of our production companies have managed to receive international quality certificates, including SE, and could export their goods to some European and South American countries," Director-General of the Food and Drug Administration of Iran for Equipment and Necessities Affairs Seyed Hossein Safavi told FNA.
"We have managed to export 363 products to 55 countries in the first 6 months of the current year," he added, saying that Iran had exported 261 types of different products to 45 states in the same period last year.
In August the country unveiled 6 new indigenized knowledge-based products with medical uses.
The products which were unveiled at Shiraz University of Medical Sciences had all been manufactured by Iranian experts.
Also, Iranian Vice-President for Science and Technology Sorena Sattari in July unveiled 8 new drugs during his a visit to the knowledge-based companies in Alborz province near Tehran.
The newly-developed drugs include Micro-Peltamparazole, Tamsulosin hydrochloride, Naltrexone base, Citalyptin phosphate, Peo gliatzone and other medicine.
The drugs have applications in treatment of digestive diseases and intestinal insufficiency, and will also be exported to the regional states.